期刊
JOURNAL OF NATURAL PRODUCTS
卷 84, 期 1, 页码 142-160出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jnatprod.0c00965
关键词
-
Plant-based therapies, particularly cannabis, have a long history of medicinal use and are now gaining renewed interest due to the discovery of the endocannabinoid system in the early 1990s. This has led to increased research and exploration of the therapeutic potential of cannabis, particularly focusing on the major constituents like Delta(9)-THC and CBD, as well as the numerous minor cannabinoids that could modulate the ECS and show therapeutic benefits individually or in combination with other phytochemicals.
Plant-based therapies date back centuries. Cannabis sativa is one such plant that was used medicinally up until the early part of the 20th century. Although rich in diverse and interesting phytochemicals, cannabis was largely ignored by the modern scientific community due to its designation as a schedule 1 narcotic and restrictions on access for research purposes. There was renewed interest in the early 1990s when the endocannabinoid system (ECS) was discovered, a complex network of signaling pathways responsible for physiological homeostasis. Two key components of the ECS, cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2), were identified as the molecular targets of the phytocannabinoid Delta(9)-tetrahydrocannabinol (Delta(9)-THC). Restrictions on access to cannabis have eased worldwide, leading to a resurgence in interest in the therapeutic potential of cannabis. Much of the focus has been on the two major constituents, Delta(9)-THC and cannabidiol (CBD). Cannabis contains over 140 phytocannabinoids, although only a handful have been tested for pharmacological activity. Many of these minor cannabinoids potently modulate receptors, ionotropic channels, and enzymes associated with the ECS and show therapeutic potential individually or synergistically with other phytocannabinoids. The following review will focus on the pharmacological developments of the next generation of phytocannabinoid therapeutics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据